KRTL BioTech

LSE says no plans to revisit savings target from Refinitiv deal

LSE says no plans to revisit savings target from Refinitiv deal

The London Stock Exchange said it has no plans to change its targets for synergies from its planned $27 billion takeover of data and analytics company Refinitiv.